Company Yubo International Biotech Limited Other OTC
Equities
YBGJ
US9883661004
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Health Management and Health Maintenance Services
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +479.84% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +479.84% |
Managers
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Wang Yang
BRD | Director/Board Member | 45 | 18-12-31 |
Lina Liu
DFI | Director of Finance/CFO | 45 | 18-12-31 |
Zhi Hui Bai
BRD | Director/Board Member | 39 | 19-12-31 |
Jun Wang
CEO | Chief Executive Officer | 57 | 18-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,447 | 0 | 0 | 6.632 % |
Stock B | 1 | 119,816,343 | 7,945,985 ( 6.632 %) | 0 |
Company contact information
Yubo International Biotech Ltd.
Room 105, Building 5 31 Xishiku Avenue
100034, Beijing
+
http://www.yubogroup.comSector
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |